Shikiar Asset Management Inc Uro Gen Pharma Ltd. Transaction History

Shikiar Asset Management Inc

$378 Million
Q4 2024

A detailed history of Shikiar Asset Management Inc transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Shikiar Asset Management Inc holds 10,750 shares of URGN stock, worth $106,640. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,750

Previous 10,750 -0.0%

Holding current value

$106,640

Previous $137,000 16.79%

% of portfolio

0.03%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$12.72 - $19.2 $286,200 - $432,000	-22,500 Reduced 67.67%	10,750 $180,000
Q1 2022 Apr 13, 2022	SELL	$5.92 - $9.73 $592 - $973	-100 Reduced 0.3%	33,250 $290,000
Q3 2021 Oct 29, 2021	SELL	$14.31 - $18.39 $286,200 - $367,800	-20,000 Reduced 37.49%	33,350 $561,000
Q2 2021 Jul 16, 2021	BUY	$15.2 - $20.94 $273,600 - $376,920	18,000 Added 50.92%	53,350 $815,000
Q1 2021 May 05, 2021	SELL	$17.99 - $26.96 $82,754 - $124,016	-4,600 Reduced 11.51%	35,350 $689,000
Q4 2020 Feb 03, 2021	SELL	$17.54 - $25.43 $80,684 - $116,978	-4,600 Reduced 10.33%	39,950 $720,000
Q3 2020 Oct 28, 2020	SELL	$18.81 - $26.42 $124,616 - $175,032	-6,625 Reduced 12.95%	44,550 $859,000
Q2 2020 Aug 20, 2020	SELL	$16.5 - $29.7 $22,687 - $40,837	-1,375 Reduced 2.62%	51,175 $1.34 Million
Q1 2020 May 01, 2020	SELL	$13.68 - $34.6 $198,018 - $500,835	-14,475 Reduced 21.6%	52,550 $937,000
Q4 2019 Jan 28, 2020	BUY	$21.11 - $34.86 $15,304 - $25,273	725 Added 1.09%	67,025 $2.24 Million
Q3 2019 Oct 29, 2019	BUY	$23.83 - $36.44 $42,894 - $65,592	1,800 Added 2.79%	66,300 $1.58 Million
Q2 2019 Jul 25, 2019	SELL	$32.75 - $40.35 $517,450 - $637,530	-15,800 Reduced 19.68%	64,500 $2.32 Million
Q1 2019 Apr 30, 2019	BUY	$35.47 - $54.55 $207,499 - $319,117	5,850 Added 7.86%	80,300 $2.97 Million
Q4 2018 Feb 01, 2019	SELL	$38.35 - $50.39 $152,441 - $200,300	-3,975 Reduced 5.07%	74,450 $3.21 Million
Q3 2018 Nov 05, 2018	BUY	$41.65 - $51.7 $1.26 Million - $1.57 Million	30,300 Added 62.96%	78,425 $3.7 Million
Q2 2018 Jul 27, 2018	BUY	$48.35 - $65.33 $123,292 - $166,591	2,550 Added 5.6%	48,125 $2.4 Million
Q1 2018 Apr 16, 2018	BUY	$38.64 - $57.54 $948,612 - $1.41 Million	24,550 Added 116.77%	45,575 $2.27 Million
Q4 2017 Jan 26, 2018	SELL	$27.28 - $43.26 $2,046 - $3,244	-75 Reduced 0.36%	21,025 $782,000
Q3 2017 Oct 20, 2017	BUY	$17.15 - $32.72 $361,864 - $690,392	21,100	21,100 $665,000

Others Institutions Holding URGN

# of Institutions

137

Shares Held

36.2M

Call Options Held

57.7K

Put Options Held

9.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $226M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.

Account

Shikiar Asset Management Inc Uro Gen Pharma Ltd. Transaction History